The importance of genetic diagnosis for Duchenne muscular dystrophy

被引:239
作者
Aartsma-Rus, Annemieke [1 ,2 ,3 ]
Ginjaar, Ieke B. [4 ]
Bushby, Kate [2 ,3 ]
机构
[1] Leiden Univ, Dept Human Genet, Med Ctr, NL-2300 RA Leiden, Netherlands
[2] Univ Newcastle, John Walton Muscular Dystrophy Res Ctr, Newcastle, NSW, Australia
[3] Univ Newcastle, MRC Ctr Neuromuscular Dis, Inst Med Genet, Newcastle, NSW, Australia
[4] Leiden Univ, Med Ctr, Lab Diagnost Genome Anal, Leiden, Netherlands
基金
英国医学研究理事会;
关键词
Muscle disease; Diagnosis; Genetics; MANIFESTING CARRIERS; NONSENSE MUTATION; DMD; DELETIONS; TRANSLOCATION; DATABASE; DMD/BMD; FRAME;
D O I
10.1136/jmedgenet-2015-103387
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
Duchenne muscular dystrophy (DMD) and Becker muscular dystrophy are caused by mutations in the dystrophin-encoding DMD gene. Large deletions and duplications are most common, but small mutations have been found as well. Having a correct diagnosis is important for family planning and providing proper care to patients according to published guidelines. With mutation-specific therapies under development for DMD, a correct diagnosis is now also important for assessing whether patients are eligible for treatments. This review discusses different mutations causing DMD, diagnostic techniques available for making a genetic diagnosis for children suspected of DMD and the importance of having a specific genetic diagnosis in the context of emerging genetic therapies for DMD.
引用
收藏
页码:145 / 151
页数:7
相关论文
共 50 条
[21]   Expert recommendation: treatment of nonambulatory patients with Duchenne muscular dystrophy [J].
Bernert, Guenther ;
Hahn, Andreas ;
Koehler, Cornelia ;
Meyer, Sascha ;
Schara, Ulrike ;
Schlachter, Kurt ;
Trollmann, Regina ;
Walter, Maggie C. .
NERVENARZT, 2021, 92 (04) :359-366
[22]   Duchenne muscular dystrophy in Saudi Arabia: a review of the current literature [J].
Aldharee, Hitham .
FRONTIERS IN NEUROLOGY, 2024, 15
[23]   GNE Myopathy and Duchenne Muscular Dystrophy in Two Moroccans Families [J].
Sifeddine, Najat ;
Amalou, Ghita ;
Charif, Majida ;
Nahili, Halima ;
Bouzidi, Ayman ;
Salaheddine, Redouane ;
Morjane, Iman ;
Zouiri, Ghizlane ;
Kriouile, Yamna ;
Elkhalfi, Bouchra ;
Lenaers, Guy ;
Barakat, Abdelhamid .
MLTJ-MUSCLES LIGAMENTS AND TENDONS JOURNAL, 2023, 13 (04) :653-659
[24]   Current Outline of Exon Skipping Trials in Duchenne Muscular Dystrophy [J].
Eser, Gokce ;
Topaloglu, Haluk .
GENES, 2022, 13 (07)
[25]   Golodirsen for Duchenne muscular dystrophy [J].
Anwar, S. ;
Yokota, T. .
DRUGS OF TODAY, 2020, 56 (08) :491-504
[26]   Update on Duchenne muscular dystrophy [J].
Leiva-Cepas, F. ;
Montano Martinez, A. ;
Lopez-Lopez, I .
MEDICINA DE FAMILIA-SEMERGEN, 2021, 47 (07) :472-481
[27]   Casimersen for Duchenne muscular dystrophy [J].
Wilton-Clark, H. ;
Yokota, T. .
DRUGS OF TODAY, 2021, 57 (12) :707-717
[28]   Novel Mutation of the Dystrophin Gene in a Child with Duchenne Muscular Dystrophy [J].
Jiang, Jingjing ;
Jiang, Tiejia ;
Xu, Jialu ;
Shen, Jue ;
Gao, Feng .
FETAL AND PEDIATRIC PATHOLOGY, 2018, 37 (01) :1-6
[29]   A new era in the management of Duchenne muscular dystrophy [J].
Korinthenberg, Rudolf .
DEVELOPMENTAL MEDICINE AND CHILD NEUROLOGY, 2019, 61 (03) :292-+
[30]   CERULOPLASMIN IN PATIENTS WITH DUCHENNE MUSCULAR-DYSTROPHY [J].
REYES, J ;
HOLMGREN, J ;
COLOMBO, M .
REVISTA MEDICA DE CHILE, 1991, 119 (03) :258-261